San Diego-based mostly Viking Therapeutics marked alone as a significant competitor from the weight loss drug market place in February following revealing promising info from a mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when given for a weekly injection and in March the company unv